MassBio Member News
Have news you'd like to share with the wider biotechnology community? Send your press release, announcements and other news to communications@massbio.org.
Showing news: 61–70 of 582
Michael Hammerschmidt Named VP for Development of the Life Sciences Foundation
February 19, 2013 —
SAN FRANCISCO, February 19, 2013— Michael Hammerschmidt became vice president for development of the Life Sciences Foundation effective February 19, 2013. The Life Sciences Foundation is a nonprofit organization dedicated to capturing the…
Read More
February 14, 2013 —
The Massachusetts Life Sciences Center (MLSC) and the Massachusetts Medical Device Industry Council (MassMEDIC) launched the Massachusetts Medical Technology Veterans Program (MassMVP) today with a one-day, intensive training “boot…
Read More
TraceLink Life Sciences Cloud Named Edison Awards Finalist
February 14, 2013 —
Wakefield, MA (February 13, 2013) – TraceLink Inc. announced today that the TraceLink Life Sciences Cloud has been named a 2013 Award Finalist by the internationally renowned Edison AwardsTM. The TraceLink Life Sciences Cloud by TraceLink Inc. is…
Read More
BioVolutions opens new cell culture facility in Woburn, MA
February 13, 2013 —
February 13, 2013 - BioVolutions just opened a new cell culture facility at One Presidential Way in Woburn, MA. BioVolutions' renewed focus on cell line and bioreactor development begins with the expansion of a Research Cell Bank (RCB) to…
Read More
PCI Announces Four New Proprietary APIs During 2012
February 13, 2013 —
PCI Synthesis, Inc. (www.pcisynthesis.com), a Newburyport-based 14-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, announced the launch of…
Read More
HARLAN UNDERLINES INHALATION EXPERTISE AND CAPABILITIES
February 13, 2013 —
Harlan Laboratories Contract Research Services has expanded its capabilities in General Toxicology and Inhalation to support the chemicals, agrochemicals and pharmaceutical sectors with the arrival of Brian Anderson as Manager of Safety Assessment,…
Read More
Workshop: In-Depth Characterization of Recombinant Protein Therapeutics
February 13, 2013 —
Monday, February 25 2013 6:30 pm – 8:30 pm
Location: Boston Mariott Newton
Use of Mass Spectrometry and Biophysical Methods to Overcome Challenges in Characterizing Proteins, Peptides, Antibodies, & Biosimilars
Discussion will…
Read More
Dr. Mickey Urdea Joins Pressure BioSciences’ Board of Directors
February 12, 2013 —
Founder of Tethys Bioscience and Halteres Associates, Previous Diagnostics R&D and Business Head at Chiron and Bayer, and Member of Multiple Scientific Advisory Boards Brings Extensive Expertise and Experience to PBI
South Easton, MA,…
Read More
Bach Pharma, Inc. Appoints Mr. Dan Cato as President
February 12, 2013 —
North Andover, Massachusetts, USA (February 1, 2013) – During the recent Meeting of the Board of Directors of Bach Pharma, Inc., Chairman of the Board Dr. Steven L. Stroup announced the appointment of Mr. Daniel Cato of Durham, North Carolina to the…
Read More
Rhenovia Pharma recognized as the world leader in biosimulation of the central nervous system
February 8, 2013 —
Five years after foundation, an independent study performed by MarketsandMarkets recognizes Rhenovia as the world leader in biosimulation for research into drugs for diseases of the central nervous system
In 2013, the company is preparing to gather a…
Read More
Membership Deliverables
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.